1. Ligand-Directed Chemistry of AMPA Receptors Confers Live-Cell Fluorescent Biosensors
- Author
-
Seiji Sakamoto, Itaru Hamachi, Yuma Morikawa, Sho Wakayama, Shigeki Kiyonaka, and Muneo Tsujikawa
- Subjects
Cell ,Biosensing Techniques ,AMPA receptor ,Ligands ,010402 general chemistry ,01 natural sciences ,Biochemistry ,Fluorescence ,Drug Discovery ,medicine ,Humans ,Protein complex formation ,Receptors, AMPA ,Fluorescent Dyes ,010405 organic chemistry ,Ligand ,Chemistry ,musculoskeletal, neural, and ocular physiology ,Glutamate receptor ,General Medicine ,0104 chemical sciences ,HEK293 Cells ,medicine.anatomical_structure ,nervous system ,Biophysics ,Molecular Medicine ,Biosensor ,Function (biology) - Abstract
AMPA-type glutamate receptors (AMPARs) mediate fast excitatory synaptic transmission in the central nervous system. Dysregulation of AMPAR function is associated with many kinds of neurological, neurodegenerative, and psychiatric disorders. As a result, molecules capable of controlling AMPAR functions are potential therapeutic agents. Fluorescent semisynthetic biosensors have attracted considerable interest for the discovery of ligands selectively acting on target proteins. Given the large protein complex formation of AMPARs in live cells, biosensors using full-length AMPARs retaining original functionality are ideal for drug screening. Here, we demonstrate that fluorophore-labeled AMPARs prepared by ligand-directed acyl imidazole chemistry can act as turn-on fluorescent biosensors for AMPAR ligands in living cells. These biosensors selectively detect orthosteric ligands of AMPARs among the glutamate receptor family. Notably, the dissociation constants of agonists and antagonists for AMPARs were determined in live cells, which revealed that the ligand-binding properties of AMPARs to agonists are largely different in living cells, compared with noncellular conditions. We also show that these sensors can be applied to detecting allosteric modulators or subunit-selective ligands of AMPARs. Thus, our protein-based biosensors can be useful for discovering pharmaceutical agents to treat AMPAR-related neurological disorders.
- Published
- 2018
- Full Text
- View/download PDF